Literature DB >> 9542801

Epidemiology of alcohol and medication as aids to sleep in early adulthood.

E O Johnson1, T Roehrs, T Roth, N Breslau.   

Abstract

STUDY
OBJECTIVES: In a representative sample of adults 18-45 years of age, this study addressed three questions about the use of sleep aids in the general population: (1) what are the past-year prevalences of the use of alcohol, over-the-counter medication and prescription medication to facilitate sleep? (2) among those who use these substances for sleep problems, what are the patterns of use? and (3) are there social factors, independent of sleep characteristics, that increase the likelihood of alcohol and medication use to aid sleep?
DESIGN: The 1996 Detroit Area Survey was a random-digit-dial, computer-assisted survey of a representative sample of 2,181 adults ages 18-45 in the Detroit primary metropolitan statistical area. Eligible household response rate was 86.8%.
RESULTS: In the general population, use of alcohol and medication as sleep aids in the past year was found to be fairly common: 13% used alcohol, 18% used medications and 5% used both. The prevalence of any substance use to aid sleep was 26%. The duration of use was short for the majority of users, less than 1 week. However, duration of use was greater for the majority of those using prescription sleep aids. A substantial minority of users report regular use lasting longer than 1 month: 15%, 9%, and 36% for alcohol, OTC medications, and prescription medications, respectively. Both sociodemographic and sleep characteristics were associated with alcohol and medication use to aid sleep. Difficulty falling asleep was the factor most strongly associated with use of substances to improve sleep. Sex, race/ethnicity, work shift, marital status and education were also significantly associated with one or more types of sleep aid use adjusting for difficulty falling asleep.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9542801     DOI: 10.1093/sleep/21.2.178

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  56 in total

Review 1.  Hypnotics: an update.

Authors:  Timothy Roehrs; Thomas Roth
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

2.  Utilization of hypnotic medication in the context of cancer: predictors and frequency of use.

Authors:  Lucie Casault; Josée Savard; Hans Ivers; Marie-Hélène Savard; Sébastien Simard
Journal:  Support Care Cancer       Date:  2011-06-03       Impact factor: 3.603

3.  The influence of chronic respiratory conditions on health status and work disability.

Authors:  Mark D Eisner; Edward H Yelin; Laura Trupin; Paul D Blanc
Journal:  Am J Public Health       Date:  2002-09       Impact factor: 9.308

4.  Sleep Health and Appropriate Use of OTC Sleep Aids in Older Adults-Recommendations of a Gerontological Society of America Workgroup.

Authors:  Steven M Albert; Thomas Roth; Michael Toscani; Michael V Vitiello; Phyllis Zee
Journal:  Gerontologist       Date:  2015-10-28

Review 5.  Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework.

Authors:  George F Koob; Ian M Colrain
Journal:  Neuropsychopharmacology       Date:  2019-06-24       Impact factor: 7.853

Review 6.  Treatment options for sleep disturbances during alcohol recovery.

Authors:  J Todd Arnedt; Deirdre A Conroy; Kirk J Brower
Journal:  J Addict Dis       Date:  2007

7.  Insomnia and the performance of US workers: results from the America insomnia survey.

Authors:  Ronald C Kessler; Patricia A Berglund; Catherine Coulouvrat; Goeran Hajak; Thomas Roth; Victoria Shahly; Alicia C Shillington; Judith J Stephenson; James K Walsh
Journal:  Sleep       Date:  2011-09-01       Impact factor: 5.849

Review 8.  Alcohol disrupts sleep homeostasis.

Authors:  Mahesh M Thakkar; Rishi Sharma; Pradeep Sahota
Journal:  Alcohol       Date:  2014-11-11       Impact factor: 2.405

Review 9.  [The importance of sleep for healthy alcohol consumers and alcohol dependent patients].

Authors:  H Gann; D van Calker; B Feige; D Riemann
Journal:  Nervenarzt       Date:  2004-05       Impact factor: 1.214

10.  Pharmacological Interactions between the Dual Orexin Receptor Antagonist Daridorexant and Ethanol in a Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Four-Way Crossover Phase I Study in Healthy Subjects.

Authors:  Benjamin Berger; Sander Brooks; Rob Zuiker; Muriel Richard; Clemens Muehlan; Jasper Dingemanse
Journal:  CNS Drugs       Date:  2020-11-18       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.